Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Molecular Cytogenetics|June 28, 2017
Scattered genomic amplification in dedifferentiated liposarcomaNils Mandahl, Linda Magnusson, Jenny Nilsson, et al.
The Journal of Pathology|July 18, 2019
Undifferentiated pleomorphic sarcomas with PRDM10 fusions have a distinct gene expression profileJakob Hofvander, Florian Puls, Nischalan Pillay, et al.
Journal of Pediatric Hematology/Oncology|November 7, 2012
Biphasic, hyperdiploid breast tumors in children: a distinct entity?Charles Walther, David Gisselsson, Linda Magnusson, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 6, 2023
Osteosarcomas With Few Chromosomal Alterations or Adult Onset Are Genetically HeterogeneousValeria Difilippo, Karim H Saba, Emelie Styring, et al.
Oncology Reports|December 4, 2013
Rearrangements of chromosome bands 15q12-q21 are secondary to HMGA2 deregulation in conventional lipomaGemma Macchia, Karolin H Nord, Giuseppina D'Alessandro, et al.
Cancer Genetics|November 27, 2012
SNP array and FISH findings in two pleomorphic hyalinizing angiectatic tumorsArezoo Mohajeri, Lars-Gunnar Kindblom, Vaiyapuri P Sumathi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 15, 2020
PHF1 fusions cause distinct gene expression and chromatin accessibility profiles in ossifying fibromyxoid tumors and mesenchymal cellsJakob Hofvander, Vickie Y Jo, Christopher D M Fletcher, et al.
Cancer Genetics|December 25, 2019
Genomic and transcriptomic features of dermatofibrosarcoma protuberans: Unusual chromosomal origin of the COL1A1-PDGFB fusion gene and synergistic effects of amplified regions in tumor developmentJan Köster, Elsa Arbajian, Björn Viklund, et al.
The Journal of Pathology. Clinical Research|February 6, 2020
NTRK fusions in osteosarcoma are rare and non-functional eventsBaptiste Ameline, Karim H Saba, Michal Kovac, et al.
Genes, Chromosomes & Cancer|August 21, 2021
Amplification of ERBB2 (HER2) in embryonal rhabdomyosarcoma: A potential treatment target in rare cases?Shamik Mitra, Saskia Sydow, Linda Magnusson, et al.
Pageof 8